Ezacard 75 mg 30 tablets

Tradename

Ezakard

Ezacard

Composition

Each enteric-coated tablet contains:

Acetylsalicylic Acid 75mg

Properties

Ezakard is a salicylate NSAID that has a bloodthinning effect.

Indications

ischemic stroke, acute myocardial infarction, prevention of recurrent myocardial infarction, unstable angina pectoris and chronic stable angina pectoris. Reducing the risk of death in patients with ischemic stroke; with chronic stable angina pectoris. The following procedures include coronary artery bypass grafting, percutaneous transluminal coronar angioplasty, and carotid endarterectomy.

Mode of application:

inside, the tablet should be swallowed whole. Secondary prevention of thrombotic cerebrovascular or cardiovascular diseases: 75-300 mg per day. For angina pectoris: 75150 mg per day.

Side effects

the tablets do not irritate the stomach. May occur: bronchospasm, gastrointestinal hemorrhage (sometimes extensive) and other hemorrhages.

Storage method:

Store at a temperature not exceeding 30C, out of reach of children.